Literature DB >> 16480953

vCJD prion acquires altered virulence through trans-species infection.

Masahiro Asano1, Shirou Mohri, James W Ironside, Mamoru Ito, Norikazu Tamaoki, Tetsuyuki Kitamoto.   

Abstract

Variant Creutzfeldt-Jakob disease (vCJD) appears to be caused by infection with the bovine spongiform encephalopathy (BSE) agent. To date, all patients with vCJD are homozygous for methionine at codon 129 of the PrP gene. To investigate the relationship between polymorphism at codon 129 and susceptibility to BSE or vCJD prions, we performed splenic follicular dendritic cell assay with humanized knock-in mice through peripheral infection. All humanized knock-in mice showed little or no susceptibility to BSE prions. Only the subset of humanized knock-in mice with codon 129 Met/Met genotype showed weak susceptibility by Western blotting. Surprisingly, we succeeded in the transmission of vCJD prions to humanized knock-in mice not only with codon 129 Met/Met but also with codon 129 Met/Val. Humanized knock-in mice with codon 129 Val/Val were not susceptible. The results suggest that human heterozygotes at codon 129 are also at risk for secondary infection with vCJD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16480953     DOI: 10.1016/j.bbrc.2006.01.149

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  16 in total

1.  Distinctive properties of plaque-type dura mater graft-associated Creutzfeldt-Jakob disease in cell-protein misfolding cyclic amplification.

Authors:  Atsuko Takeuchi; Atsushi Kobayashi; Piero Parchi; Masahito Yamada; Masanori Morita; Shusei Uno; Tetsuyuki Kitamoto
Journal:  Lab Invest       Date:  2016-02-15       Impact factor: 5.662

2.  α2,3 linkage of sialic acid to a GPI anchor and an unpredicted GPI attachment site in human prion protein.

Authors:  Atsushi Kobayashi; Tetsuya Hirata; Takashi Nishikaze; Akinori Ninomiya; Yuta Maki; Yoko Takada; Tetsuyuki Kitamoto; Taroh Kinoshita
Journal:  J Biol Chem       Date:  2020-04-22       Impact factor: 5.157

3.  Co-occurrence of types 1 and 2 PrP(res) in sporadic Creutzfeldt-Jakob disease MM1.

Authors:  Atsushi Kobayashi; Kenta Mizukoshi; Yasushi Iwasaki; Hajime Miyata; Yasuji Yoshida; Tetsuyuki Kitamoto
Journal:  Am J Pathol       Date:  2011-03       Impact factor: 4.307

4.  Characterization of variant Creutzfeldt-Jakob disease prions in prion protein-humanized mice carrying distinct codon 129 genotypes.

Authors:  Atsuko Takeuchi; Atsushi Kobayashi; James W Ironside; Shirou Mohri; Tetsuyuki Kitamoto
Journal:  J Biol Chem       Date:  2013-06-21       Impact factor: 5.157

5.  Immunohistochemical characterization of cell types expressing the cellular prion protein in the small intestine of cattle and mice.

Authors:  Kohtaro Miyazawa; Takashi Kanaya; Sachi Tanaka; Ikuro Takakura; Kouichi Watanabe; Shyuichi Ohwada; Haruki Kitazawa; Michael T Rose; Suehiro Sakaguchi; Shigeru Katamine; Takahiro Yamaguchi; Hisashi Aso
Journal:  Histochem Cell Biol       Date:  2006-12-13       Impact factor: 4.304

6.  Transmission properties of atypical Creutzfeldt-Jakob disease: a clue to disease etiology?

Authors:  Atsushi Kobayashi; Piero Parchi; Masahito Yamada; Paul Brown; Daniela Saverioni; Yuichi Matsuura; Atsuko Takeuchi; Shirou Mohri; Tetsuyuki Kitamoto
Journal:  J Virol       Date:  2015-01-21       Impact factor: 5.103

7.  Experimental verification of a traceback phenomenon in prion infection.

Authors:  Atsushi Kobayashi; Nobuyuki Sakuma; Yuichi Matsuura; Shirou Mohri; Adriano Aguzzi; Tetsuyuki Kitamoto
Journal:  J Virol       Date:  2010-01-20       Impact factor: 5.103

Review 8.  Heterozygous inhibition in prion infection: the stone fence model.

Authors:  Atsushi Kobayashi; Masaki Hizume; Kenta Teruya; Shirou Mohri; Tetsuyuki Kitamoto
Journal:  Prion       Date:  2009-01-23       Impact factor: 3.931

Review 9.  Molecular pathology of human prion disease.

Authors:  Jonathan D F Wadsworth; John Collinge
Journal:  Acta Neuropathol       Date:  2010-08-08       Impact factor: 17.088

Review 10.  Review: contribution of transgenic models to understanding human prion disease.

Authors:  J D F Wadsworth; E A Asante; J Collinge
Journal:  Neuropathol Appl Neurobiol       Date:  2010-12       Impact factor: 8.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.